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Structured Summary  
Aims 
Prescribing is a complex task and a high-risk area of clinical practice.  Poor prescribing occurs 
across staff grades and settings but new prescribers are attributed much of the blame.  New 
prescribers are frequently neither confident nor competent to prescribe and they are likely 
to have different support and development needs than their more experienced colleagues.  
Unfortunately, little is known about what interventions are effective in this group.  Previous 
systematic reviews have not distinguished between different grades of staff, have been 
narrow in scope and are now out of date.  Therefore, to inform the design of educational 
interventions to change behaviour of new prescribers, we conducted a systematic review of 
existing hospital-based interventions. 
 
Methods 
Embase, Medline, SIGLE, Cinahl and PsychINFO were searched for relevant studies published 
1994-2010.  Studies describing interventions to change the behaviour of new prescribers in 
hospital settings were included.  The bibliographies of included papers were also searched 
for relevant studies.  Interventions and effectiveness were classified using existing 
frameworks and the quality of studies was assessed using a validated instrument. 
 
Results 
Sixty four studies were included in the review. Only 13% interventions specifically targeted 
new prescribers. Most interventions (72%) were deemed effective in changing behaviour 
but no particular type or types stood out as most effective.  
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Conclusion 
Very few studies have tailored educational interventions to meet needs of new prescribers, 
or distinguished between new and experienced prescribers. More research is required if 
healthcare educators are to support new prescriber and improve this important aspect of 
early clinical practice. 
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Introduction 
Prescribing is a complex, challenging task and a high-risk area of clinical practice (1).  
Prescribing errors are common, affecting 7% medication orders, 2% patient days and 50% 
hospital admissions (2). Studies have identified a range of factors underpinning poor 
prescribing at individual, environmental and organisational levels (3). These include lack of 
training, low perceived task importance and lack of awareness of errors, as well as 
increasingly complex polypharmacy and patient factors, lack of standardization, and 
particular care environments (4-6).  
 
There is evidence of poor prescribing across different grades of staff and in different settings 
(5) with new prescribers in particular being attributed a lot of the blame (5, 7). Studies have 
found that new prescribers are neither confident nor competent when prescribing, both by 
their own assessment and that of their supervisors (8-10).  Many excellent initiatives have 
focussed on improving prescribing knowledge and technical skills (e.g. Hospital Pharmacy 
Initiative (11); Medical Schools Councils Safe Prescribing Working Group (12)).  However 
improving prescribing knowledge and technical skills is not enough. Prescribing is a complex 
mix of knowledge, skills and behaviours and there is no simple relationship between them 
(13, 14). The skills and experience of new prescribers must develop as they work within an 
environment where any positive gains may be negated by the numerous complex and 
overwhelming pressures that may influence prescribing behaviour.   
 
The behaviour change literature is large and growing, supported by research funding to 
explore the theory and practice of behaviour change, and the development and evaluation 
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of behaviour change interventions. The challenges inherent in studying behaviour change 
are widely recognised.  Behaviour change not only involves individual capability, opportunity 
and motivation but the fact that it takes place in a complex healthcare system adds another 
layer of complexity to the equation (15).  There is a plethora of behaviour change theories 
and frameworks, and behaviour change interventions are equally diverse, leading to 
challenges of nomenclature (16).  A useful way of categorising types of intervention is 
offered by Bero et al. (17) and this has been adopted in systematic reviews that aimed to 
determine educational strategies that were effective in changing physician performance and 
healthcare outcomes (but not necessarily prescribing behaviours) (18, 19).  Davis et al. (19) 
included only randomised controlled trials and found that commonly used educational 
approaches like didactic presentations had little impact, whereas reminders, patient-
mediated interventions, outreach visits, opinion leaders and multifaceted activities were 
more effective.  Bloom (18) reviewed systematic reviews to examine effectiveness of 
current CME tools and techniques in changing physician clinical practices and improving 
patient health outcomes and found that interactive techniques such as audit/feedback, 
academic detailing/outreach and reminders were more effective  at changing physician care 
and patient outcomes than guidelines, opinion leaders, didactic presentations and printed 
information. Unfortunately, Bloom concluded that “Even though the cost-effective CME 
techniques have been proven, use of least-effective ones predominates”. 
 
In order to inform the design of educational interventions that can change the behaviours of 
new prescribers, we conducted a systematic review of existing interventions.  There is no 
similar study to our knowledge.  The most similar review was conducted by Gill et al (20) but 
it had a narrow methodological scope (only randomised controlled trials and non-equivalent 
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group designs), did not distinguish between grades of prescriber and is now out of date 
(only including studies up until 1994). Our study will update this review by identifying 
educational interventions that aimed to change the behaviour of new prescribers in hospital 
settings using a deliberately inclusive approach to definitions of educational interventions 
and study design.   
 
Methods 
Search Strategy 
The databases used in the systematic review by Gill et al. (20) that are still in use were 
searched (Embase; Medline; SIGLE), in addition to Cinahl and PsychINFO.  The searches were 
carried out on the 8th and 9th of November 2010 and searched for relevant items published 
between 1994 and November 2010. 
 
The databases were searched for the following free text keywords in a variety of 
combinations “prescribing or drug administration or drug prescription or drug utilisation or 
drug utilization or drug prescription” and “medical education or continuing medical 
education or nursing education or dental education or clinical education”  depending on the 
database. Subject headings relevant to each database were also used for example MeSH 
and Emtree. See Table 1 for details of the search used in Medline. 
 
The bibliographies of included papers identified by our search of electronic databases were 
searched for relevant items by NB & KM. Abstracts were sought for the papers that were 
considered to be potentially relevant. The inclusion criteria were then applied to these 
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papers. In addition, the title, abstract or keywords needed to contain the words education 
to keep in line with our search strategy.  
 
Inclusion Criteria 
For the purposes of this review, prescribing was defined as the act of determining what 
medication a patient should have and the correct dosage and duration of treatment (21). 
The following inclusion criteria were adopted: 
 Aspect of prescribing - all studies that focused on developing one or more aspect of 
prescribing as defined above. Studies focusing only on drug administration were not 
included.  
 Study design – all study designs were included.  
 Types of settings – all studies that were conducted in hospital settings. This was the 
setting we were most interested in as the purpose of the review was to inform the 
design of an educational intervention that develops the behavioural aspects of 
prescribing in new prescribers, and the vast majority of new prescribers are based in 
hospital settings. Furthermore we felt that the interventions and reasons 
underpinning why they might work may be different between hospital and primary 
care.  
 Types of participants – all studies that included doctors, nurses, dentists or other 
healthcare professionals that prescribe and are in the early stages of their careers 
i.e. qualified but <2 years post graduation. If the study participants involved all 
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prescribers in a hospital setting (which would include new prescribers) then it was 
included.  
 Types of intervention – interventions or resources that focus on changing or 
developing the behavioural aspects of prescribing.   
 Outcome measures – all prescribing related outcome measures were accepted.  
 Language – studies published in English language. 
 Data Collection and Analysis 
One review author (NB) assessed the potential relevance of all titles and abstracts identified 
from the electronic searches. As a reliability measure, the first 10% of the titles and 
abstracts were assessed independently and then compared by the two review authors (NB 
& KM). If a difference was found the issue was discussed. The remaining title and abstracts 
(90%) were assessed independently by NB. If NB had any doubts about particular studies 
while assessing them they were resolved by discussion with KM. A categorisation system 
was developed to categorise excluded papers (Figure 1). 
 
Data Extraction and Quality Appraisal  
The papers of all eligible studies were obtained and read in full and data were extracted by 
each review author. Data were extracted independently using a standardised review form. 
Interventions were categorised using the same classification as the Gill(20) study which was 
based on Bero et al (see Table 2). Where possible the pre and post test scores were 
extracted but some studies failed to report these and in these cases the numerical or 
percentage change were reported instead. The effectiveness of interventions were 
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categorised using a modified version of the classification system used in the Gill (20) study 
(see Table 3). It was not possible to use an identical framework to Gill et al. because this 
relied on the statistical significance of change in the outcomes measured and very few of 
our included studies conducted this type of analysis. Our modified approach is described in 
Table 3 and the categorisation was applied independently by both NB and KM. >95% 
agreement was reached between KM and NB using this method. The few differences that 
were found were discussed and agreement was reached.  
 
The quality of studies were appraised using the medical education research study quality 
instrument (MERSQI) (Table 4) (22).  This tool was the most appropriate for this review 
because the majority of interventions included in the study had an educational, conference 
or training element to the intervention. Furthermore the majority of studies were 
observational or experimental and the MERSQI was designed for these study designs. The 
six items on the MERSQI scale (study design, sampling, type of data, validity of evaluation 
instrument, data analysis, and outcomes) were scored on a scale of 1 to 3 and summed to 
determine a total MERSQI score. The maximum score for each domain was 3, producing a 
maximum possible MERSQI score of 18 and potential range of 5 to 18. The total MERSQI 
score was calculated as the percentage of total achievable points (accounting for “non 
applicable” responses) and then adjusted to a standard denominator of 18 to allow for 
comparison of scores across studies (22). Both reviewers independently scored the papers 
using the MERSQI tool and consistent scores were found. 
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Results 
Literature Identified 
The search identified 5,966 potentially relevant articles and after the exclusions were 
applied 53 articles satisfied the inclusion criteria (Figure 1). Checking the references of the 
53 included items identified 11 more relevant studies. The 64 studies included in the 
analysis are listed in Table 5.  
Description of Studies 
Only 13% of interventions specifically focussed on new prescribers. The majority of studies 
were conducted in the USA and Canada (39%) and Europe (33%) (Table 5). In terms of 
clinical area, 38% were conducted in internal medicine, 27% were carried out in all clinical 
areas and 13% were carried out in paediatrics. A variety of drug types were involved, with 
the largest group being antibiotics (32%). 
The majority of studies were single group pre test and post test (72% n=46), with the 
remainder being either non-randomized 2 group (11%, n=7), randomised control trials (9%, 
n=6) and single group cross-sectional or single group post test only (8%, n=5). Nearly all of 
the interventions were multifaceted (89%) using a variety of combinations of interventions. 
Within the 64 eligible studies there were 157 separate interventions (Table 2) with 
educational materials (28%), conferences and training (23%) and audit and feedback (18%) 
being the most popular.  A variety of outcome measures were used in the studies but the 
most common were the rates of prescribing, rates of appropriate/inappropriate prescribing, 
prescribing errors, adherence to dosage guidelines and cost savings. The majority of 
interventions were classified as being effective (72%): 45% received a + and 27% received a 
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++. Of the 17 (27%) most successful strategies (classified as ++) 6 provided specific feedback 
to prescribers (e.g. audit and feedback (23-28) and  7 required active engagement with the 
process (e.g. reminders (26, 29-34).  However, 7 of the 8 studies classified as ineffective also 
contained these intervention types (35-41). 
 
Quality of Studies 
Total MERSQI scores among the 64 studies ranged from 6 to 18 with a mean (SD) of 13.3 
(1.7) (Table 6). Mean domain scores were highest for type of data (3.0), data analysis (2.8) 
and outcomes (2.0). Only 19.4% of studies were multi-institutional. All of the studies 
measured a behavioural outcome, two of which included patient outcomes.   
Discussion 
The aim of this systematic review was to identify educational interventions that aimed to 
change behaviour of new prescribers.  A previous systematic review explored this topic but 
had a narrow methodological scope, did not focus on new prescribers and is now out of 
date.  We focussed on the hospital setting since this is where the majority of new 
prescribers are based and since we felt the issues facing prescribers in primary and 
secondary care were probably different, and might require different strategies for behaviour 
change. 
 
We identified a reasonable size literature relevant to our aim. However, only 19% of studies 
distinguished between different grades of prescriber and even fewer (13%) focussed on new 
prescribers.  A systematic review investigating the effectiveness of education interventions 
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whose target population was medical students and junior doctors similarly found a very 
small number of studies on junior doctors (3). The limited focus on new prescribers probably 
reflects the predominant use of before and after studies where the outcome measure was 
hospital pharmacy data or patient notes.  It is not possible and / or labour intensive to 
differentiate between grades of staff in these data sources.  New prescribers are a very 
distinct group with different educational needs than more experienced prescribers and we 
think that different behaviour change strategies will be effective thus it is important that 
educational interventions are designed specifically to target this group.  
 
The educational interventions reported in the included studies were varied and were mainly 
used in various combinations.  The findings show that 72% of interventions were deemed 
effective in changing prescribing behaviour in the intended direction. However, similar to 
the Gill et al. study (20), no clear differences in the effectiveness of particular types or 
combinations of interventions could be deciphered. This contrasts with the Davis (19), 
Bloom (18) and Grindod (42) studies which found particular types of interventions like audit 
and feedback, reminders, outreach were consistently effective (although none of these 
studies contained information on the sustainability of effect of these interventions). The 
inconsistencies in findings is probably related to the fact that prescribing behaviour is 
complex and therefore, by definition, unpredictable.  Interventions to improve professional 
performance are complex and “any cogent interpretation of the results of these studies 
requires a disentangling of the variation in the characteristics of the targeted professionals, 
the targeted behaviours and the study designs”(43).  Our data suggest that a successful 
strategy in one setting may not be successful in another setting.   
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Only 11% of our studies reported single interventions compared to 67% in the Gill et al. 
study. This shows a marked temporal shift from single to multifaceted interventions. While 
our study did not provide reliable evidence that multifaceted interventions were more 
effective, other studies have indicated that this is the case (42, 44).  Furthermore there were 
only 6 RCTs included in our study compared with 64 in the Gill et al. review and we believe 
this finding represents a real decrease in the number of RCTs performed.  This shift may 
reflect an increasing awareness that RCTs are limited in their ability to help us understand a 
complex behaviour like prescribing, although there are a number of other possible 
explanations.  
 
Our research aimed to identify educational interventions that were designed to effect 
behavioural change in new prescribers. Despite including all types of study design, there was 
very little that contributed to the picture of why or how particular behaviour change 
strategies produced their effect and this is an important next step.  Mixed methods study 
designs will be important in this respect and different types of systematic review such as a 
realist review may also be helpful (45). Traditional methods of review focus on measuring 
and reporting the effectiveness of interventions but provide limited information as to why 
the intervention worked or did not work when applied in different contexts or 
circumstances, deployed by different stakeholders, or used for different purposes (45). A 
realist review is designed to work with complex social interventions or programmes and 
provides an explanatory analysis aimed at discerning what works, for whom, in what 
circumstances, in what respects.   
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The strengths of the research approach were the considerable efforts that went into 
locating relevant studies. Publication bias is the most important source of bias in systematic 
reviews (46).  This is likely the case in this study, given that the majority of the interventions 
were effective. One wonders whether the authors would have sought to publish them if 
they had not had the desired effect.   
 
A limitation of this review is the subjective nature of the direction and magnitude of the 
effect scores. While the MERSQI scale was helpful for assessing the quality of studies, like 
most quality assessment tools it did have some limitations. The perfect score of 3.0 for type 
of data was because the quality scale is not applicable to prescribing interventions included 
in this review, so by nature of the inclusion criteria, all the studies got a perfect score on this 
component. Other limitations were the reliance on pre-post test designs which can be 
confounded by improvement of prescriber with time and clinical experience, another is the 
possible absence of blinding in studies with risk of observer bias, and finally selective 
outcome reporting with a tendency to report favourable outcome measures in the 
manuscript.  
 
In terms of future research, behaviour change strategies targeting specific grades of 
prescriber are urgently needed if we are to reduce the morbidity and mortality resulting 
from prescribing errors. Quantitative studies (such as a before and after study with a control 
hospital, or an RCT) could be enhanced by the inclusion of a process evaluation to unpick 
the possible reasons underpinning prescribing behaviours (47) as none of the studies in this 
review included this element.  
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Table 1: Medline Search 
 
1. "Drug Utilization Review"/ or Drug Prescriptions/ or Drug Utilization/ or drug 
utilisation.mp. 
2. prescription drugs.mp. or Drug Prescriptions/ or Prescription Drugs/ 
3. medication errors.mp. or Medication Errors/ 
4. prescribing.tw. 
5. (drug$ adj4 administ$).tw. 
6. (drug$ adj4 prescri$).tw. 
7. (drug$ adj4 utilisation).tw. 
8. (drug$ adj4 utilization).tw. 
9. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 
10. medical education.mp. or Education, Medical/ 
11. continuing medical education.mp. or Education, Medical, Continuing/ 
12. nursing education.mp. or Education, Nursing/ 
13. dental education.mp. or Education, Dental/ 
14. Education, Professional/ or Education, Medical/ 
15. Education, Medical/ or clinical education.mp. [mp=title, original title, abstract, name of 
substance word, subject heading word, unique identifier] 
16. Education, Medical/ or Education, Medical, Graduate/ or doctor training/ or 
interprofessional education.mp. 
17. 10 or 11 or 12 or 13 or 14 or 15 or 16 
18. 9 and 17 
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Table 2: Classification and Types  of Intervention (20)  
Type of Intervention 
No. of 
Interventions 
% 
Educational materials: 
 Distribution of published or printed recommendations for clinical care, 
including clinical practice guidelines, audiovisual materials and electronic 
publications 44 28 
Conferences & Training:  
Participation of healthcare providers in conferences, lectures, workshops or 
traineeships outside their practice settings. Practice settings are defined as on 
the ward or in their office. But could be taking place in a room on the hospital 
site. 
36 23 
Audit & Feedback: 
 Any summary of clinical performance of health care over a specified period, 
with or without recommendations for clinical action. The information can have 
been obtained from medical records, computerised databases or patients or 
by observation including a knowledge test. 
27 17 
Outreach Visits:  
Use of a trained person who meets with providers in their practice settings to 
provide information. The information given may include feedback on the 
providers performance. Practice settings are defined as on the ward or in their 
office. But could be taking place in a room on the hospital site. 
15 10 
Reminders:  
Any intervention (manual or computerised) that prompts the healthcare 
provider to perform a clinical action. Examples include concurrent or inter-visit 
reminders to professionals about desired actions such as screening or other 
preventative services, enhanced laboratory reports or administrative support 
(e.g. follow-up appointment systems or stickers on charts, order forms or 
physician order entry systems). 
24 15 
Marketing: 
 Use of personal interviewing, group discussion (focus groups) or a survey of 
targeted providers to identify barriers to change and the subsequent design of 
an intervention and refinement. 
9 6 
 Patient-mediated interventions:  
Any intervention aimed at changing the performance of health care providers 
for which information was sought from or given directly to patients by others 
(e.g. direct mailings to patients, patient counselling delivered by others, or 
clinical information collected directly from patients and given to the provider) 
1 1 
Local opinion leader:  
Use of providers explicitly nominated by their colleagues to be educationally 
influential  
 1 1 
Total  157 100 
 
This is a post-print author’s draft of an article accepted for publication in the journal British Journal of Clinical 
Pharmacology 2013. DOI:10.1111/j.1365-2125.2012.04397.x  
18 
 
Table 3: Classification of Effectiveness of Intervention 
Effectiveness of Intervention Symbol 
Intervention was  ineffective or demonstrated no intended effect o 
Intervention resulted in a change in the opposite direction - 
Intervention resulted in a positive change of 20-50% from baseline, in the majority of 
outcomes measured at the first post measure. If one outcome was classified as a + and 
one was a ++, the overall classification was a +.  
+ 
Intervention resulted in a positive change of >50% from baseline in the majority of 
outcomes measured at  the first post measure 
++ 
Intervention resulted in a variable change of outcome measures and included both a 
positive (+ or ++) and a negative (-) or ineffective outcome (0).   
v 
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Table 4: MERSQI Scale 
 
Domain  MERSQI Item Item 
Score 
Please 
put x in 
relevant 
box 
Study Design 1.  Study design   
  Single group cross-sectional or single group post test only 1  
 Single group pre test and post test 1.5  
 Nonrandomized, 2 group 2  
 Randomized controlled trial 3  
Sampling 2. No. of institutions studied   
 1 0.5  
 2 1  
 >2 1.5  
3. Response rate, %   
 Not applicable   
 < 50 or not reported 0.5  
 50-74 1  
 >- 75 1.5  
Type of data 4. Type of data   
 Assessment by study participant 1  
 Objective measurement 3  
Validity of 
evaluation 
instrument 
5. Internal structure   
 Not applicable   
 Not reported 0  
 Reported 1  
6. Content   
 Not applicable   
 Not reported 0  
 Reported 1  
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7. Relationships to other variables   
 Not applicable   
 Not reported 0  
 Reported 1  
Data 
analysis 
8. Appropriateness of analysis   
 Data analysis inappropriate for study design or type of data 0  
 Data analysis appropriate for study design and type of data 1  
9. Complexity of analysis   
 Descriptive analysis only 1  
 Beyond descriptive analysis 2  
Outcomes 10. Outcomes   
 Satisfaction, attitudes, perceptions, opinions, general facts 1  
 Knowledge, skills 1.5  
 Behaviours 2  
 Patient/health care outcome 3  
Total Score     
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Table 5: Studies of effects of interventions on prescribing behaviour of new prescribers   
  Context Methods Results Study Quality 
 Study 
Country of 
study 
Clinical 
area 
Type of new 
prescriber 
Drug 
prescribed 
Study design 
A = Single 
group cross-
sectional or 
single group 
post test only 
B= Single 
group pre test 
& post test 
C= Non-
randomized, 2 
group 
D=Randomized 
control trials 
Type of 
intervention(s) 
 
Outcome 
measures 
Pre & post measures 
Effectiveness of 
Intervention 
(o) = ineffective 
(+) = moderately 
effective 
(++) = highly effective 
MERSQI Score out of 18 
1. 
Akter et al 
(2009)(48) 
Bangladesh Paediatrics 
All 
prescribing 
doctors 
Antibiotics C 
Conferences & 
training 
Inappropriate 
antimicrobial use 
(pneumonia & 
diarrhoea) 
83.1 to 66.7%, 86.8% 
to 28.0 % 
+ 
15 
2. 
Allenet et al 
(2004)(49) 
France Medicine 
All 
prescribers 
Not specified A 
Outreach visits, 
audit & 
feedback 
Rate of 
acceptance of 
pharmacy 
residents 
recommendations 
47% & 80% 
acceptance 
No baseline data – not 
possible to calculate 10 
3. 
Angalakuditi et 
al              
(2005)(50) 
Australia Paediatrics 
All 
prescribing 
doctors 
Antibiotics C 
Educational 
materials, audit 
& feedback 
1. Appropriate 
antibiotic choice 
2. Dosage 
1. 48% to 84.7% 
2. 0 to 58.2% 
+ 
15 
4. 
Apisarnthanarak 
et al     
(2006)(51) 
Thailand 
All clinical 
areas  
All 
prescribers 
Antibiotics B 
Educational 
materials, 
conferences & 
training, 
reminders 
1. Rate of 
prescription 2. 
Inappropriate use 
3. Drug resistant 
infection 4. Cost 
1. 64 to 40% 
2. 42 to 20% 
3. 48 to 33.5% 
+ 
13 
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savings 4. $84,450 to 
$52,219 
5. 
Apisarnthanarak 
et al     
(2007)(35) 
Thailand 
Medicine 
& Surgery 
All 
prescribers 
Antibiotics B 
Educational 
materials, 
reminders 
Rate of  
inappropriate 
antibiotic use 
20 to 23% 0 
13 
6. 
Apisarnthanarak 
et al       
(2010)(52) 
Thailand 
All clinical 
areas 
Doctors, 
residents, 
interns and 
medical 
students 
Antifungals B 
Educational 
materials, 
reminders 
1.Rate of 
prescription 2. 
Rate of 
inappropriate 
drug use, 3. Cost 
savings 
1. 194 to 80 
2.  71 to 24% 
3. $31,615 (baseline 
data absent) 
++ 
13 
7. 
Bantar et al 
(2003)(53) 
Argentina 
All clinical 
areas  
All 
prescribers 
Antibiotics B 
Audit and 
feedback, 
reminders, 
marketing 
1. Antibiotic use 
2.  Cost 
1. 431 to 276 
2. $261,955 to 
$57,245 
+ 
13 
8. 
Belgamwar 
(2005)(29) 
UK Medicine 
All 
prescribers 
Parenteral 
Thiamine 
B 
Educational 
materials 
Average number 
of monthly 
prescriptions 
1. 79 to 208 ++ 
14 
9. 
Bell         
(2002)(54) 
USA 
All  clinical 
areas  
All 
prescribers 
Antibiotics B 
Educational 
materials, audit 
& feedback 
1. Antibiotic use 
2. Antibiotic 
claims 3. Cost 
Not possible to 
report due to large 
number of data from 
different 
organisations 
+ 
13 
10. 
Bergqvist  
(2009)(55) 
Sweden Medicine 
All 
prescribing 
nurses 
All drugs B 
Conferences & 
training 
1. Drug-related 
readmissions 2. 
Rate of 
inappropriate 
drug use 
1. 36.1 to 37.6% 
2. 17.6 to 17.2 
O 
14 
11. 
Buckmaster et 
al (2006)(56) 
Australia 
Emergency 
Medicine 
Junior 
doctors 
Heparin & 
enoxaparin 
C 
Educational 
materials, 
outreach visits, 
reminders, 
marketing 
 
Inappropriate 
drug use 
90% decrease ++ 
15 
12. 
Burmester et al 
(2008)(57) 
USA Paediatrics 
All 
prescribers 
Not specified B 
Outreach visits, 
audit & 
1. Prescribing 
errors 2. 
1. 16.8 to 8.4% + 
13 
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feedback, 
reminders 
Incomplete 
prescriptions 3. 
Adverse drug 
events 
2. 15.3 to 3.6% 
3. 1.3 to 1.1% 
13. 
Buyle et al  
(2010)(58) 
Belgium 
Medicine 
& Surgery 
All 
prescribing 
doctors 
Antibiotics B 
Educational 
materials, 
conferences & 
training, 
reminders 
1. Ratio of 
consumption 2.  
Number of days 
beyond advised IV 
3. Cost 
1. 44.5 to 41.2% 
2. 4.1 to 3.5 
3. €188 to €103 
v 
13 
14. 
Campino et al 
(2009)(30) 
Spain Pediatrics 
All 
prescribers 
 
All drugs not 
related to 
enteral and 
parenteral 
nutrition and 
blood products 
B 
Conferences & 
training 
1. Medication 
errors 2. % of 
drug prescriptions 
with one or more 
incident 3. Ability 
to identify 
prescribing 
physicians 
1. 20.7 to 3% 
2. 19.2 to 2.9% 
3. 1.3 to 78.2% 
++ 
13 
15. 
Carson et al 
(2009)(59) 
Ireland 
All clinical 
areas  
All 
prescribing 
doctors and 
nurses 
Opiods B 
Educational 
materials, 
conferences & 
training,  audit 
& feedback, 
outreach visits 
1. Rate of drug 
errors 
1. 54 to 17 ++ 
12 
16. 
Caswell et al 
(2006)(60) 
UK Medicine 
Junior 
doctors & 
nurses 
Hypnotics B 
Conferences & 
training, 
educational 
materials  
1. Inpatient use of 
hypnotics 2. 
Discharge use of 
hypnotics 
1. 48 to 26% 
2. 20 to 10% 
+ 
13 
17. 
Chaturvedi et al 
(2008)(23) 
India Psychiatry 
Resident 
doctors 
Not specified B 
Audit & 
feedback 
Prescriptions 
meeting required 
standards 
8 to 40% ++ 
12 
18. 
Cohn et al 
(2006)(61) 
USA Medicine 
All 
prescribers 
VTE 
Prohpylaxis 
B 
Conferences & 
training, audit & 
feedback, 
reminders 
1. Rate of 
prophylaxis 2. 
Rate of 
appropriate 
prophylaxis 
1. 43 to 86% 
2. 68 to 85% 
+ 
13 
19. 
Corfield et al 
(2006)(24) 
UK Surgery 
Nurses & 
junior 
doctors 
Cardiac drugs B 
Educational 
materials, audit 
& feedback 
1. Proportion of 
patients with 
cardiac drugs 
1. 42 to 20% ++ 
13 
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omitted 2.  
Proportion of 
patients with a 
drug omitted with 
the reason stated 
as ‘nil by mouth’ 
2. 13.3 to 0% 
20. 
Cote et al 
(2008)(25) 
USA Medicine 
All 
prescribing 
doctors 
GI Prophylaxis A 
Outreach visits, 
reminders 
Use of 
gastroprotection 
26 to 55% ++ 
11 
21. 
De Melo et al 
(2008)(31) 
Brazil Medicine 
All 
prescribers 
Antibiotics B 
Outreach visits, 
marketing 
1. Use of 
inappropriate 
antibiotics 2. Cost 
savings 
1. 69.2%, 56.3% 
39.0% reduction 
2. 58.6% 
++ 
13 
22. 
De Miguel et al 
(2000)(62) 
Spain 
All clinical 
areas  
All 
prescribers 
Albumin B 
Educational 
materials, 
conferences & 
training 
1. Rate of 
appropriate 
prescribing 2. 
Cost 
1. 76 to 39% 
2. $108,750 to 
$102,950 
v 
13 
23. 
Donovan et al 
(2007)(63) 
USA Medicine Cardiologists 
Eptifibatide 
Renal dosing 
C 
Conferences & 
training 
1. Adherence rate 
to dosing 
recommendations 
1. 37 to 69% + 
15 
24. 
Foulks et al 
(1997)(36) 
USA Surgery 
All 
prescribing 
doctors & 
nurses 
Parenteral 
nutrition 
B 
Educational 
materials, 
reminders 
1. Overfeeding of 
kilocalories 2. 
Cost of delivery of 
a patient-day of 
TPN 
1. 125 to 110% & 120 
to 105% 
2. 8% decrease 
0 
14 
25. 
Frush e al 
(2006)(64) 
USA Paediatrics  
Doctors, 
nurses & 
paramedics 
Not specified C 
Conferences & 
training 
1. Dosing 
deviation 
summary  2.  
Dosing time 
summary 
1. 34.4 to 12.6% 
2. 29 to 16 
+ 
17 
26. 
Garbutt et al 
(2008)(65) 
USA 
Medicine 
& surgery 
Medical 
house staff 
& surgeons 
Not specified B 
Conferences & 
training, audit 
reminders 
Prescribing errors 
for 1. surgical and 
2. house staff 
1. 1.08 to 0.85 2. 
0.76 to 0.98 
v 
13 
27. 
Gommans et al 
(2008)(66) 
New 
Zealand 
All clinical 
areas  
Doctors & 
nurses 
Not specified B 
Educational 
materials, 
conferences & 
training, audit & 
Documentation of 
medical charts 
including 1. 
1. 14 to 97% ++ 
12 
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feedback, 
reminders 
Legibility, 2. 
Patient 
identification, 3. 
Documentation of 
date, 4. Drug dose 
5. Use of 
medication alerts 
6. Prevalence of 
verbal orders 
2. 58 to 81% 
3. 11% to 98% 
4. 11% to 99% 
5.  53 to 98% 
6. 15 to <1% 
28. 
Gordon et al 
(2000)(37) 
USA 
All clinical 
areas 
All 
prescribers 
Meperidine B 
Educational 
materials, 
conferences, 
audit & 
feedback, 
reminders 
Use of 
meperidine 
1. 12 to 11% 0 
12 
29. 
Gyssens et al 
(1997)(67) 
Netherlands Medicine 
Medical 
students, 
residents, 
junior & 
senior staff 
members 
Antibiotics B 
Conferences & 
training, 
educational 
materials, 
reminders, 
audit & 
feedback 
1. Defined daily 
doses of 
antimicrobial use 
2. Compliance 
with order form 
1. 31 to 21% 
2. 40 to 53% 
+ 
13 
30. 
Kaye et al 
(2005)(38) 
Australia 
Emergency 
medicine 
All 
prescribing 
doctors 
Analgesics C 
Educational 
materials, audit 
& feedback, 
marketing 
Dosage units of 
parenteral 
analgesics 
62 vs  56% 0 
14 
31. 
Khali et al 
(2010)(68) 
Iran Medicine 
All 
prescribing 
doctors 
Acid 
suppressive 
therapy 
B 
Educational 
materials, 
conferences & 
training, 
outreach visits 
Appropriate drug 
use 
1. 81 to 48% + 
12 
32. 
Kozer et al 
(2006)(39) 
Canada Paediatrics  
Interns & 
resident 
doctors 
Not specified A 
Conferences & 
training, audit & 
feedback 
Rate of 
prescribing errors 
12.4% vs 12.7% 0 
11 
33. 
Le Claire et al 
(2006)(40) 
USA Medicine 
Medical 
house staff 
officers, 
physicians & 
pharmacists 
Antibiotics B 
Educational 
materials, 
reminders 
Appropriate drug 
use 
45 to 51% 0 
13 
34. 
Leonard et al 
(2006)(69) 
USA Paediatrics 
All 
prescribers 
All drugs B 
Educational 
materials, audit 
& feedback 
1. Absolute risk 
reduction, 2.  
Potential adverse 
drug event 
1. 38 to 49% 
2. 78 to 35.3% 
+ 
13 
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35. 
Lewis et al 
(2010)(26) 
UK 
All clinical 
areas  
All 
prescribing 
doctors 
Insulin B 
Conferences & 
training, audit & 
feedback 
Number of 
incorrect 
abbreviations 
37.5 to 15.5% ++ 
13 
36. 
Lipsky et al 
(1999)(70) 
USA 
All clinical 
areas 
All 
prescribers 
Antibiotics B 
Educational 
materials, 
outreach visits, 
marketing  
Rate of 
inappropriate 
prescribing 
70 to 40% + 
13 
37. 
Lutters et al 
(2004)(71) 
Switzerland Medicine 
All 
prescribers 
Antibiotics B 
Educational 
materials, 
conferences & 
training 
sessions, 
outreach visits, 
audit & 
feedback 
1. Mean number 
of prescribed 
drugs 2. 
Proportion of 
patients exposed 
to antibiotic 
agents 3. Number 
of antibiotics 
administered. 4. 
Cost of antibiotic 
use 
1. 5.9 to 7.6% 
2. 15% reduction 
3. 26% reduction 
4. 54% reduction 
v 
13 
38. 
McQuillan et al 
(1996)(72) 
UK Medicine 
All 
prescribing 
doctors & 
nurses 
Analgesics B 
Educational 
materials, 
conferences & 
training, local 
opinion leader 
1. Rate of 
appropriate 
prescribing for a 
variety of 
analgesic types 2. 
pain scores 
1. 6.2 to 13.7%, 5.6 
to 14.4% , 7.3 to 
0.7%, 6 to 6% 2. 15 
too 22% 
v 
15 
39. 
Metlay et al 
(2007)(41) 
USA 
Emergency 
medicine 
All 
prescribers 
Antibiotics D 
Conferences & 
training, 
educational 
materials, 
patient-
mediated 
interventions, 
audit & 
feedback 
Inappropriate 
antibiotic use for 
1. Upper 
respiratory tract 
infection 2. Acute 
bronchitis 
1. 9.5% 
decrease 
2. 5% 
decrease 
0 
18 
40. 
O’ Connor et al 
(2005)(27) 
USA 
Medicine 
& surgery  
Residents, 
nurse 
practitioners 
& physician 
assistants 
Opiods B 
Educational 
materials, 
reminders 
Doses of 
meperidine 
37.5 to 0.22 ++ 
12 
41. 
Peeters et al 
(2009)(73) 
USA Medicine All residents Not specified B 
Conferences & 
training, 
marketing 
Frequency of 
prescribing error 
2.25 to 1.51 + 
12 
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42. 
Perez et al 
(2003)(74) 
Columbia 
Medicine, 
Surgery & 
Paediatrics 
All 
prescribers 
Antibiotics B 
Educational 
materials, 
conferences & 
training, 
reminders 
Incorrect 
prescriptions 
47, 7.3 & 20% 
reduction 
+ 
13 
43. 
Record et al 
(1995)(75) 
USA 
All clinical 
areas  
House staff 
doctors 
Antibiotics A 
Educational 
materials, 
reminders  
Compliance with 
criteria 
89% 
No baseline data – not 
possible to calculate 10 
44. 
Regal et al 
(2010)(32) 
USA Medicine 
Attending 
doctors, 
senior 
medical 
officers & 
interns 
Acid 
suppressive 
medications 
B 
Conferences & 
training, 
outreach visits  
Inappropriate 
prescribing 
59 to 19% ++ 
13 
45. 
Richards et al 
(2003)(76) 
Australia 
All clinical 
areas  
All 
prescribers 
Antibiotics B 
Conference & 
training, 
Reminders  
1. Rate of drug 
use 2. 
Concordance with 
guidelines 
1. 38.3 to 15.9 
2. 25 to 51% 
++ 
13 
46. 
Riggio et al 
(2009)(33) 
USA Medicine 
All 
prescribing 
doctors & 
nurses 
Heart failure 
drugs 
B 
Conferences & 
training, 
reminders 
Compliance 37 to 93% ++ 
13 
47. 
Roberts et al 
(2006)(77) 
Australia 
Medicine 
& Surgery 
All 
prescribers 
Warfarin A 
Educational 
materials, audit 
& feedback 
Uptake of DVT 
prophylaxis by 1. 
medical patients 
2. Surgical 
patients 
1. 52.8 to 67% 2. 
86.1 to 84.1 % 
v 
13 
48. 
Roth et al 
(2001)(78) 
USA 
All clinical 
areas  
All 
prescribing 
doctors, 
residents & 
physician 
extenders 
Anticoagulants, 
histamine type 
2 blockers & 
non steroidal 
anti-
inflammatory 
drugs 
B 
Educational 
materials, audit 
& feedback, 
reminders  
Total 
prescriptions 
32%, 50%, 28% 
decrease 
+ 
13 
49. 
Ruttiman et al 
(2004)(79) 
Switzerland Medicine 
All 
prescribers 
Antibiotics B 
Educational 
materials, 
conferences 
and training 
sessions, 
outreach visits, 
audit & 
feedback 
1. Antibiotic 
consumption 2. 
Cost of antibiotics 
1. 36% decrease 
2. 53% decrease 
+ 
13 
50. 
Sarasin et al 
(1999)(80) 
Switzerland Medicine 
All 
prescribing 
doctors 
Beta blockers B 
Educational 
materials, 
conferences & 
Prescription of 
beta blockers at 
1. 38 to 63% + 
13 
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training, 
reminders 
discharge 
51. 
Seto et al (1996) 
(81) 
Hong Kong 
All clinical 
areas 
All 
prescribers 
Antibiotics B 
Educational 
materials, 
conferences & 
training 
sessions, audit 
& feedback, 
marketing  
1. Admissions 
prescribed IV 
sultamicillin or 
coamoxiclav 2. 
Cost 
1. 38 & 75% 
reduction 
2. 43% decrease 
+ 
13 
52. 
Shaw et al 
(2003)(82) 
Australia 
All clinical 
areas  
Junior 
doctors 
Drugs of 
addiction 
C 
Educational 
materials, 
marketing 
1. Rate of errors 
2. Confidence of 
junior doctors in 
writing 
prescriptions 
1. 41 to 24% 
2. 3.25 to 4.14 
+ 
15 
53. 
Shah et al(83) 
(2003) 
USA Paediatrics Residents 
Paediatric 
drugs 
D 
Educational 
materials, 
conferences & 
training,  
Deviation from 
recommended 
dose range 
25.4% decrease + 
15 
54. 
Simpson et al 
(2004)(34) 
Scotland Paediatrics 
All 
prescribers 
Paediatric 
drugs 
B 
Educational 
materials, 
outreach visits, 
audit and 
feedback 
Monthly 
medication errors 
24.1 to 5.1 ++ 
13 
55. 
Solomon et al 
(2001)(84) 
USA Medicine 
Intern & 
resident 
doctors 
Antibiotics D 
Educational 
materials, audit 
& feedback 
Unnecessary drug 
use(days) 
37% decrease + 
15 
56. 
St. Pierre et al 
(2005)(28) 
USA Medicine 
All 
prescribing 
doctors, 
nurse 
pharmacists 
& therapists 
Delerogenic  
drugs 
B 
Educational 
materials, 
conferences & 
training 
Frequency of 
medication use 
57% reduction ++ 
12 
57. 
Sterne et al 
(1996)(85) 
USA 
All clinical 
areas  
All 
prescribers 
Ranitidine B 
Educational 
materials, 
outreach visits, 
reminders 
1. Appropriate 
drug use  2. 
Appropriate 
dosage form 3. 
Cost savings 
1. 74 to 96% 
2. 87 to 94% 
3. $1,080 to $180 
+ 
13 
58. 
Thamlikitkul et 
al (1998)(86) 
Thailand 
All clinical 
areas  
Student 
doctors, 
residents & 
doctors 
Antibiotics B 
Educational 
materials, 
conferences & 
training, audit & 
feedback 
1. Antibiotic use 
2. Cost of 
antibiotics 
1. 20% decrease 
2. 20% decrease 
+ 
13 
59. 
Thompson et al 
(2008)(87) 
UK Psychiatry 
All 
prescribers 
Antipsychotics D 
Educational 
materials, 
Polypharmacy 
Ranging from a 
reduction of 26% to 
v 
17 
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outreach visits,   
reminders 
prescribing rates an increase of 7% 
60. 
Thompson et al 
(2010)(88) 
UK Psychiatry 
All 
prescribing 
doctors & 
nurses 
Antipsychotic 
drugs 
D 
Educational 
materials 
Proportion of 
antipsychotic 
polypharmacy 
prescribing 
Ranging from a 
reduction of 26% to 
an increase of 7% 
v 
17 
61. 
Ungavari et al 
(1997)(89) 
Hong Kong Psychiatry 
All 
prescribers 
Psychotropic 
drugs 
B 
Educational 
materials, 
conferences & 
training, audit & 
feedback 
Drug use 54.3 to 34.2 + 
13 
62. 
Van Hees et al 
(2008)(90) 
Netherlands 
Medicine 
& Surgery 
All 
prescribers 
Antibiotics B 
Conferences & 
training, 
marketing 
1. Quantity of 
prescriptions 2. 
Quality of 
prescriptions 
1. 81 to 32 
2. 53.6 to 75.7 
+ 
13 
63. 
Webbe et al 
(2007)(91) 
UK 
Emergency 
medicine 
& 
medicine 
Junior 
doctors 
Not specified D 
Educational 
materials, 
conferences & 
training, 
outreach visits,  
audit & 
feedback 
1. Rate of 
prescribing errors 
2. Performance 
on prescribing 
assessment 
1. 37.5% reduction 
2.  55 to 61 
+ 
15 
64. 
Zamin et al 
(1997)(92) 
Canada Medicine 
Residents, 
interns, 
medical 
students & 
pharmacists 
Antibiotics B 
Educational 
materials, 
conferences & 
training 
sessions 
Inappropriate 
prescribing 
41 to 26% + 
12 
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Table 6: Scores of Included Studies on applicable MERSQI Domains  
MERSQI Domains Total 
Achievable 
Score 
Mean 
Score 
% Mean 
Score 
Standard 
Deviation 
Study Design 3 1.7 57% 0.5 
Sampling 1.5 0.7 47% 0.4 
Type of Data 3 3.0 100% 0.2 
Data analysis 3 2.8 93% 0.4 
Outcomes 3 2.0 66% 0.2 
Total Score 13.5* 9.8 73% 1.7 
 
* Note – MERSQI scores in Table 5 were calculated as the percentage of total achievable 
points (accounting for “non applicable” responses) and then adjusted to a standard 
denominator of 18 
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Fig 1: Flow Chart of Study Selection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5, 966  
Potentially 
relevant items  
 
1,213 duplicates  excluded 
 
4,753  
Titles and 
abstracts 
screened 
    4,700 excluded 
Reasons for exclusion: 
1. Not relevant (4,077) 
2. Not in English language (330) 
3. Addressed the topic of interest but failed 
on one or more criteria including (293): 
a. Healthcare setting (198) 
b. Not new prescriber (75) 
c. Irrelevant aspect of prescribing (13) 
d. Could not track down a copy of 
paper (7) 
 
 
Database search identified: 
 4,390 items in EMBASE   
 892 items in Medline   
 156 items in PsychINFO  
 418 items in Cinahl   
 110 items SIGLE  
 
 
53 
papers read in full 
and data extracted Relevant 
papers 
identified 
from 53 
included 
studies (11) 64 
included studies read in 
full & data  extracted 
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